Relmada Therapeutics
RLMD
RLMD
44 hedge funds and large institutions have $1.68M invested in Relmada Therapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
-4
Holders Change %
-8.33%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
14
Closed
12
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
-$189K
Top Buyers
| 1 |
Goldman Sachs
New York
|
$32.6K |
| 2 |
Two Sigma Advisers
New York
|
$77.8K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
$75.7K |
| 4 |
HF
HRT Financial
New York
|
$14K |
| 5 |
Two Sigma Investments
New York
|
$46K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Fidelity Investments
Boston,
Massachusetts
| – | -$15.6K | -30,062 | Closed |
|
52
Dimensional Fund Advisors
Austin,
Texas
| – | -$7.5K | -14,428 | Closed |
|
|
SIG
53
Sargent Investment Group
Bethesda,
Maryland
| – | -$4.72K | -11,670 | Closed |
|
|
BCM
54
Beaumont Capital Management
Boston,
Massachusetts
| – | -$5.72K | -11,006 | Closed |
|
|
TRCT
55
Tower Research Capital (TRC)
New York
| – | -$396 | -760 | Closed |
|
56
Wells Fargo
San Francisco,
California
| – | -$104 | -200 | Closed |
|